Home Overview Press Room Blog Publications For Students about us
Search

About Inheritable Genetic Modification


The Basic Science

Frequently Asked Questions

Arguments Pro & Con

3-Person Embryos

Inheritable genetic modification (IGM, also called germline engineering) means changing the genes passed on to future generations. The genetic changes would be made in eggs, sperm or early embryos; modified genes would appear not only in the person who developed from that gamete or embryo, but also in all succeeding generations. IGM has not been tried in humans. It would be by far the most consequential type of genetic modification as it would open the door to irreversibly altering the human species.

Proposals for inheritable genetic modification in humans combine techniques involving in vitro fertilization (IVF), gene transfer, stem cells and research cloning.



Bracing For A Battle, Vermont Passes GMO Labeling Billby Eliza Barclay and Jeremy BernfeldNPRApril 24th, 2014The Green Mountain State is poised to become the first to require food companies to label products containing genetically modified ingredients.
Advocates for Children and Childhood Mobilizing on Concerns about GM Babiesby Marcy DarnovskyBiopolitical TimesApril 17th, 2014Concern about "three-person embryo" techniques is growing among advocates for children and childhood.
Stocking the Genetic Supermarket: Reproductive Genetic Technologies and Collective Action Problemsby Chris Gyngell and Thomas DouglasWiley Online LibraryApril 10th, 2014Reproductive genetic technologies targeting non-medical traits could lead to collective action problems. Does this risk justify state intervention in the genetic supermarket?
Embryo Screening and the Ethics of Human Genetic Engineering[Quotes CGS's Richard Hayes]by Leslie A. PrayIndian DefenceApril 8th, 2014In April 2008, Ronald M. Green published his case in support of the genetic engineering of embryos; Richard Hayes rebutted, warning of a "neo-eugenic future" and "the danger of genetic misuse."
Editorial: Genome editing for allNature BiotechnologyApril 8th, 2014CRISPR-Cas is about to transform how we interrogate genetic variants and model disease.
Texas High School’s “Issues Day” Takes on Human Genetic Engineeringby Jessica CussinsBiopolitical TimesMarch 26th, 2014A private San Antonio high school, Saint Mary’s Hall, holds an annual “Issues Day.” The topic this year, chosen by a committee of the junior class, was human genetic engineering.
Slowing the Rush to Genetically Modified Babiesby Enola AirdMomsRisingMarch 22nd, 2014The United Kingdom is moving closer to allowing scientists to create genetically modified children – something no country in the world currently authorizes.
Letter to HFEA: Consider the Risks of “Mitochondrial Manipulation” Discussed by the FDA by Marcy DarnovskyBiopolitical TimesMarch 21st, 2014A letter signed by 53 prominent scholars and advocates has been sent to the UK agency considering clinical trials of so-called "mitochondrial manipulation."
Chinese Billionaire Funding CRISPR Research at University of Californiaby Pete ShanksBiopolitical TimesMarch 19th, 2014Li Ka-shing funds a new institute devoted to genomic editing and company development, as questions are raised about the distortions charitable donations cause to research funding.
Majority of UK Women Oppose Legalizing the Creation of "3-Person Embryos"by Jessica CussinsBiopolitical TimesMarch 19th, 2014A just-completed poll has found that the UK public is deeply conflicted about the government's move to legalize the creation of "3-person embryos."
Displaying 1-10 of 366  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760